Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Renal Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Renal Cancer
    TopAbstracts in Renal Cancer 03/17/2010 - (DGNews)
    Cytoreductive Nephrectomy Improves Overall Survival With VEGF Agents in Renal Cancer: Presented at ASCO-GU - (DGDispatch)
    Sorafenib Provides Safe, Long-Lasting Control in Older Patients With Renal Cell Carcinoma: Presented at ASCO-GU - (DGDispatch)
    Hypertension May Be Biomarker for Sunitinib Efficacy: Presented at ASCO-GU - (DGDispatch)
    Bone Metastasis Growth Following Radiation May Be Normal, Not Progression: Presented at ASCO-GU - (DGDispatch)

    News archive

     Recent webcasts/CME - Renal Cancer

    Webcasts/CME archive

     Recent cases - Renal Cancer
      Giant Renal Oncocytoma: A Case Report And Review Of The Literature
      Synchronous Lingual and Thyroid Metastasis from Renal Cell Carcinoma
      Granulocytosis and Thrombocytosis in Renal Cell Carcinoma: A Pro-Inflammatory Cytokine Response Originating in the Tumour
      Xp11.2 Translocation Renal Cell Carcinoma Occurring During Pregnancy with a Novel Translocation Involving Chromosome 19: A Case Report with Review of the Literature
      Stauffer's Syndrome as a Prominent Manifestation of Renal Cancer: A Case Report

      Cases archive
        




      my personal edition > renal cancer > news
      divider

        E-Mail this DGNews to a colleague

      DGNews


      Recipient, Donor Race May Affect Mortality in Kidney Transplantation

        By Kristina Rebelo

        SAN DIEGO -- November 25, 2009 -- A study released during the American Society of Nephrology (ASN) Renal Week 2009, documents a possibility of lower patient survival in cases of non-black patients receiving black-donor kidneys.

        The study showed that non-black donors to non-black recipients appeared to fare better in terms of survival.

        For the study, researchers used the Kaplan-Meier and Cox regression analyses to look for risk factors for kidney transplantation patient mortality.

        The group looked at recipients and donors in the United Network of Organ Sharing (UNOS) database between 1995 and 2008. UNOS reported 16,000 kidney transplants took place last year in the United States. The researchers identified and divided the groups into 4 categories based on donor and recipient race pairs of blacks and non-blacks.

        "When comparing non-black donors to non-black recipients, there appeared to be an increased risk of patient mortality," Anita Patel, MD, Internal Medicine and Nephrology, Henry Ford Transplant Institute, Detroit, Michigan, told Doctor's Guide in an interview after the conference. "We were surprised at the results in that we thought there would not be a correlation between blacks and non-blacks. The comorbidity score and infections were a risk factor in all the groups."

        After adjusting for all known variables, on regression analysis, the study found that the black donor/non-black recipient group had significantly lower survival rates (P = .01). Dr. Patel stressed that the data was retrospective and observational and that a prospective study needs to be accomplished with all transplant centres across the country contributing data.

        Risk factors associated with lower patient survival included hepatitis C infection in both donor and recipient.

        Dr. Patel recommended that before transplantation, patients with a high comorbidity score have their health issues stabilised to improve survival.

        "An important aspect of this is looking at the comorbidity score and the need to get the patients stabilised before transplantation," explained Dr. Patel. "Diabetes is a major factor; the score includes the presence or absence of diabetes, hypertension, symptomatic peripheral vascular disease and symptomatic cardiovascular disease."


        SOURCE: American Society of Nephrology Renal Week 2009




      E-Mail this DGNews to a colleague   To print, use this version






      All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send